Starling Oncology (STLN) Profit After Tax Growth (1y) (2021 - 2026)
Powered by 
Analysis
Starling Oncology (STLN) Profit After Tax Growth (1y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 90.73 Bn | 89.71 Bn | 15.19 Bn | 2.06% |
| 2 | Tenet Healthcare | 22.05 Bn | 19.88 Bn | 4.45 Bn | 100.19% |
| 3 | Encompass Health | 12.13 Bn | 12.00 Bn | 1.34 Bn | 11.95% |
| 4 | Davita | 11.78 Bn | 11.09 Bn | 1.16 Bn | 24.71% |
| 5 | Universal Health Services | 10.12 Bn | 9.98 Bn | 3.29 Bn | 0.55% |
| 6 | Ensign | 9.97 Bn | 9.64 Bn | 306.24 Mn | 18.19% |
| 7 | Chemed | 6.91 Bn | 6.87 Bn | 221.47 Mn | 28.98% |
| 8 | Pacs | 6.73 Bn | 6.57 Bn | 338.46 Mn | 49.84% |
| 9 | Concentra Group Holdings Parent | 4.30 Bn | 4.14 Bn | 192.10 Mn | 45.69% |
| 10 | Starling Oncology | 613.55 Mn | 572.46 Mn | 27.17 Mn | 42.45% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 42.45% |
| Mar 31, 2026 | 87.28% |
| Dec 31, 2025 | 43.04% |
| Sep 30, 2025 | -2.43% |
| Jun 30, 2025 | -9.88% |
| Mar 31, 2025 | 1.53% |
| Dec 31, 2024 | 29.71% |
| Sep 30, 2024 | 7.50% |
| Jun 30, 2024 | 8.39% |
| Mar 31, 2024 | 33.70% |
| Dec 31, 2023 | 33.35% |
| Sep 30, 2023 | -551.42% |
| Jun 30, 2023 | -209.87% |
| Mar 31, 2023 | -255.54% |
| Dec 31, 2022 | -177.07% |
| Sep 30, 2022 | 10.27% |
| Jun 30, 2022 | -270.14% |
| Mar 31, 2022 | 2,036.35% |
| Dec 31, 2021 | -253,899,900.00% |
| Sep 30, 2021 | -23.31% |